IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

Upending the dogma of TB latency: Will it offer new clues for vaccine research?

February 14, 2024

Nearly 150 years after the discovery of tuberculosis, researchers are still unraveling the fundamental biology and epidemiology of the germ and how best to defeat it.

Read more

IAVI Report

Will AI crack the code for antigens?

November 30, 2023

The scientific implications of artificial intelligence loom large. One tangible application is designing better vaccines.

Read more

IAVI Report

Marion Gruber, Changemaker

November 9, 2023

After more than three decades at the U.S. Food and Drug Administration, Gruber is continuing her legacy of changing the way vaccines are licensed and distributed.

Read more

IAVI Report

Painstaking progress in African vaccine manufacturing

October 31, 2023

Improving vaccine access topped the agenda at a major public health gathering in Berlin, where pandemic preparedness loomed large.

Read more

IAVI Report

It takes a village

October 4, 2023

Exploring potential synergies between B- and T-cell HIV vaccine strategies is a priority for the field given results from recent trials.

Read more

IAVI Report

Hitchhiking the mucosa

July 6, 2023

Brittany Hartwell and her lab are exploring new ways to transport vaccine antigens across mucosal barriers to trigger more protective immune responses against many pathogens, including HIV.

Read more

IAVI Report

Powering up African-based data centers

June 22, 2023

COVID-19 illustrated once again the importance of localized epidemiological data, monitoring, and analysis.

Read more

IAVI Report

COVID-19 is no longer an emergency, but its lessons better linger

May 24, 2023

Two new books illustrate why reflection and preparation are both essential to ensure a quicker and more equitable response to the next pandemic.

Read more

IAVI Report

Keeping it all in perspective

May 9, 2023

A view from Zambia on the shifting landscape of HIV vaccine research and the enduring optimism that characterizes one researcher’s drive.

Read more

IAVI Report

What will it take to improve access to vaccines?

April 13, 2023

Work is underway but obstacles to vaccine procurement and delivery for the next pandemic loom large.

Read more

IAVI Report

RSV vaccines: the latest success story

March 14, 2023

After decades of research, structure-based design efforts are yielding effective vaccines against respiratory syncytial virus. Jason McLellan explains the breakthroughs that paved the way.

Read more

IAVI Report

HIV with a touch of gray

February 27, 2023

More and more people living with HIV are over 50 years old, raising new questions about efforts to slow the aging process in a population of individuals on antiretroviral therapy.

Read more